Elevance Health delivered earnings and 2025 guidance that broadly met analysts’ expectations, likely providing some relief to investors after a challenging quarter. The fourth-quarter results marked t ...

Health-care companies rose sharply amid strong earnings.

Mark Kaye, the chief financial officer, said the company took a "very disciplined approach between competitiveness and underwriting." ...

Elevance Health's quarterly dividend has been increased by 5% to $1.71 per share. The company's president and CEO, Gail K. Boudreaux, expressed the commitment to simplifying the healthcare experience ...

Mark Kaye, the chief financial officer, said the company took a "very disciplined approach between competitiveness and underwriting." ...

Operator instructions] As a reminder, today's conference is being recorded. I would now like to turn the conference over to ...

Elevance Health posted $418 million in profit for the fourth quarter of 2024, a figure that surpassed Wall Street's ...

Shares of Elevance Health Inc. climbed over 2.5% on Thursday morning, hitting levels last seen in early December. The rise came as the health insurer reported better-than-expected fourth-quarter ...

For the full year, that translated into $175.2 billion in revenue for Elevance (a 2.9% increase over 2023), while profit hit $5.98 billion, almost identical to its total a year ago. Operating revenue ...

Elevance Health Inc.'s stock rose 2% Thursday and boosted other health-insurance stocks after the company delivered better-than-expected earnings and forecast growth for 2025, easing investor concerns ...

Elevance CEO Gail Boudreaux didn’t address the killing of UnitedHealthcare’s CEO directly on Thursday, but spent more time than usual arguing the insurer is working to improve healthcare.

Elevance Health, Inc. (NYSE: ELV) reported fourth quarter and full year 2024 results. "As part of our commitment to elevating whole health and advancing health beyond ...